Market revenue in 2023 | USD 10,324.1 million |
Market revenue in 2030 | USD 14,929.2 million |
Growth rate | 5.4% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 71.73% in 2023. Horizon Databook has segmented the North America high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
North America held the largest market share of high potency active pharmaceutical ingredients market owing to the presence of major market players & developed infrastructure and rising prevalence of various diseases in the region. The growth can be attributed to rising incidence of chronic diseases coupled with increasing demand for fast-acting and higher efficacy drugs.
Rising emphasis on personalized medicine, growing collaborations & externalization with academic research institutes, and increasing adoption of healthcare IT are among the factors anticipated to further propel the market growth in the region.
Furthermore, increasing awareness pertaining to highly potent drugs, rising demand for anti-cancer therapeutics, and growing number of biotechnology companies are some of the factors contributing to the largest share held by this region. Growing regulatory support and increasing investments in biotechnology and biopharmaceutical industries are anticipated to fuel the market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America high potency active pharmaceutical ingredients market , including forecasts for subscribers. This continent databook contains high-level insights into North America high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account